By now, it’s not news that the cannabis industry operates without any national or global regulatory oversight. The lack of industry-wide standards or protocols has led to the development of a patchy network of similar, yet unperfected, regulated markets. It's an unstable framework which has led to a frustrating and repeating pattern of scandals, many of which are entirely avoidable.
DNA sequencing helps millions of people every year learn of their ancestry, as well as, identify certain health risks based on their genetic code. But DNA for cannabis? One Canadian company is changing the future of cannabis.
For the last several decades, cannabis research in the United States has been severely restricted. Despite the growing movement for legalization, federal restrictions on the research of Schedule I substances have effectively prevented research facilities and universities from studying the plant. However, emboldened and driven by the newly legal, recreational market of California, UCLA is pioneering academia into a new era of cannabis research.
As the demand for cannabinoid products continues to climb, businesses are emerging to accommodate this need, some of which are more reputable than others. Utilizing technology, like chromatography, can help separate quality cannabis and hemp producers from the crowd.
While the cannabis industry continues to grow, law enforcement agencies are scrambling for solutions to prevent or deter driving under the influence. Although impaired driving has always been a focus of the nation’s law enforcement entities, the legalization of medicinal cannabis has raised significant concerns regarding the operation of motor vehicles while under the influence of cannabis. Taking a similar approach to alcohol, rapid roadside intoxication testing for cannabis is on the rise, and manufacturers are scrambling to bring an effective device to market.
